# FDA Inspection 1165813 - Row1 Inc. dba Regenative Labs - March 30, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/row1-inc-dba-regenative-labs/e4b46d9e-2a41-4147-9e55-8aae3004143a
Source feed: FDA_Inspections

> FDA Inspection 1165813 for Row1 Inc. dba Regenative Labs on March 30, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165813
- Company Name: Row1 Inc. dba Regenative Labs
- Inspection Date: 2022-03-30
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165813 - 2022-03-30](https://www.globalkeysolutions.net/records/fda_inspections/row1-inc-dba-regenative-labs/7f50011d-384a-4b64-bb7d-9e58a71463fa)
- [FDA Inspection 1165813 - 2022-03-30](https://www.globalkeysolutions.net/records/fda_inspections/row1-inc-dba-regenative-labs/3696136c-8da9-42db-83b7-1bf9d0c926d8)

Company: https://www.globalkeysolutions.net/companies/row1-inc-dba-regenative-labs/f8c53372-486d-40ef-af57-16d200f99f62

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d